Slate Bio Overview

  • Founded
  • 2020

Founded
  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $880K

  • Investors
  • 5

Slate Bio General Information

Description

Operator of an immunotherapeutics development platform based in Charlottesville, Virginia. The company is creating therapies that restore the body's natural immunological response in various diseases using bifunctional IL233 cytokine, providing users with a second independent synergistic pathway that has tissue selectivity and improved pharmacodynamics, at lower doses and without side effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 310 2nd Street Southeast
  • Suite B
  • Charlottesville, VA 22902
  • United States
+1 (703) 000-0000

Slate Bio Timeline

20212022
Date FoundedFinancing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Slate Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 20-Dec-2021 $880K 00.000 00.000 Completed Startup
1. Seed Round 19-Jan-2021 000 000 000 Completed Pre-Clinical Trials
To view Slate Bio’s complete valuation and funding history, request access »

Slate Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Slate Bio’s complete cap table history, request access »

Slate Bio Board Members (2)

Name Representing Role Since
Kyparissia Sirinakis Epidarex Capital Board Member 000 0000
Robert Creeden UVA LVG Seed Fund Board Member 000 0000
To view Slate Bio’s complete board members history, request access »

Slate Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Epidarex Capital Venture Capital Minority 000 0000 000000 0
PharmaDirections Corporation Minority 000 0000 000000 0
UVA LVG Seed Fund Venture Capital Minority 000 0000 000000 0
Virginia Venture Partners Venture Capital Minority 000 0000 000000 0
VTC Seed Fund Venture Capital Minority 000 0000 000000 0
To view Slate Bio’s complete investors history, request access »